ScholarIQanswers from OpenAlex & ORCID
Vladimir Coric
ResearcherPublications, citations & collaboration network
Vladimir Coric is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Vladimir Coric have?
ScholarIQindexed works
Vladimir Coric has 166 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Vladimir Coric have?
ScholarIQcitation count
Vladimir Coric has 7,958 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Vladimir Coric?
ScholarIQh-index
Vladimir Coric has an h-index of 42 in OpenAlex.
What is the i10-index of Vladimir Coric?
ScholarIQi10-index
Vladimir Coric has an i10-index of 78 in OpenAlex.
What is the OpenAlex record for Vladimir Coric?
ScholarIQopenalex
The OpenAlex for Vladimir Coric is on the source record.
What are the most-cited papers on Vladimir Coric?
ScholarIQmost cited works
A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder
Michael H. Bloch, Angeli Landeros‐Weisenberger, Ben Kelmendi, Vladimir Coric, Michael B. Bracken, James F. Leckman
Rimegepant, an Oral Calcitonin Gene–Related Peptide Receptor Antagonist, for Migraine
Richard B. Lipton, Robert Croop, Elyse Stock, David Stock, Beth Morris, Marianne Frost, Gene M. Dubowchik, Charles M. Conway, Vladimir Coric, Peter J. Goadsby
Genome-wide association study of obsessive-compulsive disorder
S. Evelyn Stewart, Dongmei Yu, Jeremiah M. Scharf, Benjamin M. Neale, Jesen Fagerness, Carol A. Mathews, Paul Arnold, Patrick Evans, Eric R. Gamazon, Lisa Osiecki, Lauren M. McGrath, Stephen A. Haddad, Jacquelyn Crane, Dianne M. Hezel, C Illman, C Mayerfeld, Anuar Konkashbaev, Chunyu Liu, Anna Pluzhnikov, А. А. Тихомиров, Christopher K. Edlund, Scott L. Rauch, R. Moessner, Peter Falkai, W. Maier, Stephan Ruhrmann, HJ Grabe, Leonhard Lennertz, Michael Wagner, Laura Bellodi, Maria Cristina Cavallini, Margaret A. Richter, Edwin H. Cook, James L. Kennedy, David Rosenberg, Dan J. Stein, Sian Hemmings, Christine Löchner, Amin Azzam, Denise A. Chavira, Eduardo Fournier, Helena Garrido, Brooke Sheppard, Paula Umaña, Dennis L. Murphy, Jens R. Wendland, Jeremy Veenstra‐VanderWeele, Damiaan Denys, Rianne M. Blom, Dieter Deforce, Filip Van Nieuwerburgh, H.G.M. Westenberg, Susanne Walitza, Karin Egberts, Tobias Renner, Eurı́pedes Constantino Miguel, Carolina Cappi, Ana Gabriela Hounie, Maria Conceição do Rosário, Aline S. Sampaio, Homero Vallada, Humberto Nicolini, Nuria Lanzagorta, Beatríz Camarena, Richard Delorme, Marion Leboyer, Carlos N. Pato, Michele T. Pato, Emanuel Voyiaziakis, Peter Heutink, Daniëlle C. Cath, Daniëlle Posthuma, Johannes H. Smit, Jack Samuels, O. Joseph Bienvenu, Bernadette Cullen, Abby J. Fyer, Marco A. Grados, Benjamin D. Greenberg, James T. McCracken, Mark A. Riddle, Ying Wang, Vladimir Coric, James F. Leckman, Michael H. Bloch, Christopher Pittenger, Valsamma Eapen, Donald W. Black, Roel A. Ophoff, E Strengman, Daniele Cusi, Maurizio Turiel, Francesca Frau, Fabìo Macciardi, J. Raphael Gibbs, M R Cookson, Andrew Singleton, Sampath Arepalli, M R Cookson, Allissa Dillman
Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial
Robert Croop, Peter J. Goadsby, David Stock, Charles M. Conway, Micaela Forshaw, Elyse Stock, Vladimir Coric, Richard B. Lipton
Safety and Tolerability of the γ-Secretase Inhibitor Avagacestat in a Phase 2 Study of Mild to Moderate Alzheimer Disease
Vladimir Coric, Christopher H. van Dyck, Stephen Salloway, Niels Andreasen, Mark Brody, Ralph Richter, Hilkka Soininen, Stephen Thein, Thomas Shiovitz, Gary D. Pilcher, Susan Colby, Linda Rollin, Randy Dockens, Chahin Pachaï, Erik Portelius, Ulf Andréasson, Kaj Blennow, Holly Soares, Charles F. Albright, Howard Feldman, Robert Berman